2,000 Shares in Revvity, Inc. (NYSE:RVTY) Bought by Penobscot Investment Management Company Inc.

Penobscot Investment Management Company Inc. acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,000 shares of the company’s stock, valued at approximately $219,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. purchased a new stake in shares of Revvity during the 3rd quarter valued at $1,579,487,000. Ceredex Value Advisors LLC purchased a new stake in Revvity in the fourth quarter valued at about $108,353,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in Revvity in the fourth quarter worth about $33,568,000. Boston Trust Walden Corp acquired a new stake in Revvity in the 4th quarter worth approximately $25,154,000. Finally, KBC Group NV acquired a new position in Revvity during the 3rd quarter valued at approximately $25,301,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Insiders Place Their Bets

In other news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on RVTY. Barclays boosted their price objective on shares of Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, January 25th. UBS Group cut Revvity from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. Robert W. Baird increased their price target on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a report on Tuesday. Stifel Nicolaus lifted their price objective on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research note on Friday, February 2nd. Finally, Raymond James increased their price objective on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $118.17.

Revvity Price Performance

NYSE:RVTY opened at $102.60 on Thursday. The company has a quick ratio of 1.77, a current ratio of 2.23 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $132.54. The stock’s 50-day moving average price is $104.70 and its 200-day moving average price is $101.32. The stock has a market capitalization of $12.67 billion, a PE ratio of 84.79, a price-to-earnings-growth ratio of 2.67 and a beta of 1.09.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.04. The business had revenue of $649.90 million during the quarter, compared to the consensus estimate of $646.83 million. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The business’s quarterly revenue was down 3.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.01 EPS. As a group, equities analysts expect that Revvity, Inc. will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.28 annualized dividend and a yield of 0.27%. Revvity’s dividend payout ratio (DPR) is currently 23.14%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.